Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(77)
•••
Comment by GorgeousGeorge1on Jun 27, 2018 9:12am
120 Views
Post# 28235259

RE:RE:RE:RE:RE:TSX Manipulation

RE:RE:RE:RE:RE:TSX Manipulation'manipulation' is very easy to execute but difficult for regulatory bodies to prove, particularly with bots executing the trades, and with imv's av volume - cheap to do effectively. LSE is rife with it, it's just something you have to accept as part of the game. One possible explanation for the end of day markdowns - brokers trying to suppress an technical interest and/or buy signals until further results are known. Got a bit of news to come 'mid year' (management's words), always better to accumulate from a lower baseline should results be good. If I had the tech I'd be doing the same.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities